​
​

Avalo Therapeutics Ownership | Who Owns Avalo Therapeutics?

OverviewForecastRevenueFinancialsChart

Avalo Therapeutics Ownership Summary

Avalo Therapeutics is owned by 61.50% institutional investors, and 38.50% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.11% of its assets in Avalo Therapeutics shares.

AVTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAvalo Therapeutics61.50%-38.50%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustryBiotech Stocks 44.85%7.67%47.48%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202242-34.38%69,378,775-10.69%611.30%14-30.00%19-32.14%
Mar 31, 202264-12.33%77,679,178-2.87%681.09%20-52.38%2886.67%
Dec 31, 202173-3.95%79,978,021-0.58%791.24%42-42.47%15-
Sep 30, 202176-80,445,353-80-73---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr10.37K0.11%-
Fidelity Extended Market Index5.14K0.05%-646.00
Northern Trust Extended Eq Market Idx2.41K0.02%-
NT Ext Equity Mkt Idx Fd - L2.41K0.02%-
Fidelity Total Market Index1.73K0.02%-
Spartan Extended Market Index Pool E1.11K0.01%1.11K
Fidelity Series Total Market Index1.03K0.01%-
Fidelity Nasdaq Composite Index758.000.01%-
NT Ext Eq Mkt Indx Fd DC Lending Tier 5372.000.00%1.00
Spartan Total Market Index Pool E341.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 27, 2023ARMISTICE CAPITAL, LLC-Sell$486.89K
Jun 26, 2023ARMISTICE CAPITAL, LLC-Sell$1.68M
Jun 26, 2023Caissa Capital Management ltd.-Sell$917.15K
Jun 26, 2023Caissa Capital Management ltd.-Sell$113.03K
Jun 20, 2023Caissa Capital Management ltd.-Buy$8.29K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q2362

AVTX Ownership FAQ

Who Owns Avalo Therapeutics?

Avalo Therapeutics shareholders are primarily institutional investors at 61.50%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Avalo Therapeutics's industry, Biotech Stocks , is 44.85%, which Avalo Therapeutics exceeds.

Does Blackrock own Avalo Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Avalo Therapeutics.

Who is the top mutual fund holder of Avalo Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Avalo Therapeutics shares, with 0.11% of its total shares outstanding invested in 10.37K Avalo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools